Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation

被引:10
|
作者
You, Dingyun [1 ]
Zhao, Hongbo [2 ]
Wang, Yan [3 ]
Jiao, Yang [2 ]
Lu, Minnan [4 ]
Yan, Shan [2 ]
机构
[1] Kunming Med Univ, Kunming City 650500, Yunnan Province, Peoples R China
[2] Kunming Med Univ, Inst Mol & Clin Med, Kunming City 650500, Yunnan Province, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 2, Kunming City 650500, Yunnan Province, Peoples R China
[4] Kunming Med Univ, Expt Ctr Med Sci Res, Kunming City 650500, Yunnan Province, Peoples R China
基金
中国国家自然科学基金;
关键词
acetylation; AIB1; breast cancer; E2F1; MOF; OVARIAN-CANCER; COACTIVATOR; AMPLIFICATION; EPIDEMIOLOGY; GENETICS; GENES;
D O I
10.14348/molcells.2016.2267
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncogene nuclear receptor coactivator amplified in breast cancer 1 (AIB1) is a transcriptional coactivator, which is overexpressed in various types of human cancers, including breast cancer. However, the molecular mechanisms regulating AIB1 function remain largely unknown. In this study, we present evidence demonstrating that AIB1 is acetylated by MOF in human breast cancer cells. Moreover, we also found that the acetylation of AIB1 enhances its function in promoting breast cancer cell proliferation. We further showed that the acetylation of AIB1 is required for its recruitment to E2F1 target genes by E2F1. More importantly, we found that the acetylation levels of AIB1 are greatly elevated in human breast cancer cells compared with that in non-cancerous cells. Collectively, our results shed light on the molecular mechanisms that regulate AIB1 function in breast cancer.
引用
收藏
页码:663 / 668
页数:6
相关论文
共 50 条
  • [1] The role of AIB1 in breast cancer
    Chang, Alan K.
    Wu, Huijian
    ONCOLOGY LETTERS, 2012, 4 (04) : 588 - 594
  • [2] The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor
    Alkner, S.
    Bendahl, P. O.
    Grabau, D.
    Malmstrom, P.
    Ferno, M.
    Ryden, L.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1244 - 1252
  • [3] Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer
    Burandt, E.
    Jens, G.
    Holst, F.
    Jaenicke, F.
    Mueller, V.
    Quaas, A.
    Choschzick, M.
    Wilczak, W.
    Terracciano, L.
    Simon, R.
    Sauter, G.
    Lebeau, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (03) : 745 - 753
  • [4] AIB1 regulates the ovarian cancer cell cycle through TUG1
    Li, L.
    Gan, Z. -H.
    Qin, L.
    Jiao, S. -H.
    Shi, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (24) : 5610 - 5617
  • [5] Somatic gene alteration of AIB1 gene in patients with breast cancer
    Shibata, A
    Hayashi, Y
    Imai, T
    Funahashi, H
    Nakao, A
    Seo, H
    ENDOCRINE JOURNAL, 2001, 48 (02) : 199 - 204
  • [6] The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer
    Lahusen, Tyler
    Henke, Ralf T.
    Kagan, Benjamin L.
    Wellstein, Anton
    Riegel, Anna T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (02) : 225 - 237
  • [7] Clinical significance of AIB1 expression in human breast cancer
    Iwase, H
    Omoto, Y
    Toyama, T
    Yamashita, H
    Hara, Y
    Sugiura, H
    Zhang, Z
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (03) : 339 - 345
  • [8] Clinical Significance of AIB1 Expression in Human Breast Cancer
    H. Iwase
    Y. Omoto
    T. Toyama
    H. Yamashita
    Y. Hara
    H. Sugiura
    Z. Zhang
    Breast Cancer Research and Treatment, 2003, 80 : 339 - 345
  • [9] Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells
    Su, Qingbo
    Hu, Sanyuan
    Gao, Haidong
    Ma, Rong
    Yang, Qifeng
    Pan, Zhenhua
    Wang, Tiantian
    Li, Feng
    ONCOLOGY, 2008, 75 (3-4) : 159 - 168
  • [10] Polymorphic repeat in AIB1 does not alter breast cancer risk
    Christopher A Haiman
    Susan E Hankinson
    Donna Spiegelman
    Graham A Colditz
    Walter C Willett
    Frank E Speizer
    Myles Brown
    David J Hunter
    Breast Cancer Research, 2